This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Aug 21;376(9741):567-8.

doi: 10.1016/S0140-6736(10)60999-3. Epub 2010 Jul 29.

Is cardiometabolic risk improved by weight-loss drugs?

Affiliations

PMID: 20673996
DOI: 10.1016/S0140-6736(10)60999-3

Comment

Is cardiometabolic risk improved by weight-loss drugs?

Arne Astrup. Lancet. 2010.

. 2010 Aug 21;376(9741):567-8.

doi: 10.1016/S0140-6736(10)60999-3. Epub 2010 Jul 29.

Author

Affiliation

¹ Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen, DK-1958 Frederiksberg, Copenhagen, Denmark. ast@life.ku.dk

PMID: 20673996
DOI: 10.1016/S0140-6736(10)60999-3

No abstract available

PubMed Disclaimer

Comment on

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, Kim DD, Dunayevich E; COR-I Study Group. Greenway FL, et al. Lancet. 2010 Aug 21;376(9741):595-605. doi: 10.1016/S0140-6736(10)60888-4. Epub 2010 Jul 29. Lancet. 2010. PMID: 20673995 Clinical Trial.

Similar articles

Contrave--a combination of bupropion and naltrexone for weight loss.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2014 Nov 10;56(1455):112-4. Med Lett Drugs Ther. 2014. PMID: 25372849 No abstract available.
Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity.
Ali KF, Shukla AP, Aronne LJ. Ali KF, et al. Expert Rev Clin Pharmacol. 2016;9(1):27-34. doi: 10.1586/17512433.2016.1100072. Epub 2015 Oct 29. Expert Rev Clin Pharmacol. 2016. PMID: 26512740 Review.
A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II).
Apovian CM, Aronne L, Rubino D, Still C, Wyatt H, Burns C, Kim D, Dunayevich E; COR-II Study Group. Apovian CM, et al. Obesity (Silver Spring). 2013 May;21(5):935-43. doi: 10.1002/oby.20309. Obesity (Silver Spring). 2013. PMID: 23408728 Free PMC article. Clinical Trial.
What cost weight loss?
Hiatt WR, Thomas A, Goldfine AB. Hiatt WR, et al. Circulation. 2012 Mar 6;125(9):1171-7. doi: 10.1161/CIRCULATIONAHA.111.023499. Circulation. 2012. PMID: 22392864 No abstract available.
Melatonin, Liraglutide, and Naltrexone/Bupropion for the Treatment of Obesity and Medication-Related Weight Gain.
Howland RH. Howland RH. J Psychosoc Nurs Ment Health Serv. 2015 Jun;53(6):19-22. doi: 10.3928/02793695-20150526-02. J Psychosoc Nurs Ment Health Serv. 2015. PMID: 26091546 Review.

See all similar articles

Cited by

Effect of soybean milk fermented with Lactobacillus plantarum HFY01 isolated from yak yogurt on weight loss and lipid reduction in mice with obesity induced by a high-fat diet.
Li C, Liu H, Yang J, Mu J, Wang R, Zhao X. Li C, et al. RSC Adv. 2020 Sep 15;10(56):34276-34289. doi: 10.1039/d0ra06977a. eCollection 2020 Sep 10. RSC Adv. 2020. PMID: 35519026 Free PMC article.
Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date.
Caixàs A, Albert L, Capel I, Rigla M. Caixàs A, et al. Drug Des Devel Ther. 2014 Sep 18;8:1419-27. doi: 10.2147/DDDT.S55587. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25258511 Free PMC article. Review.
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide.
Astrup A, Carraro R, Finer N, Harper A, Kunesova M, Lean ME, Niskanen L, Rasmussen MF, Rissanen A, Rössner S, Savolainen MJ, Van Gaal L; NN8022-1807 Investigators. Astrup A, et al. Int J Obes (Lond). 2012 Jun;36(6):843-54. doi: 10.1038/ijo.2011.158. Epub 2011 Aug 16. Int J Obes (Lond). 2012. PMID: 21844879 Free PMC article. Clinical Trial.
Comparative efficiency and safety of pharmacological approaches to the management of obesity.
Hainer V. Hainer V. Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S349-54. doi: 10.2337/dc11-s255. Diabetes Care. 2011. PMID: 21525481 Free PMC article. No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information